— Know what they know.
Not Investment Advice
Also trades as: GLS (NYSE) · $vol 0M · GLS-WT (NYSE) · $vol 0M

GLSHQ OTC

Gelesis Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $7334 mcap · 35M float · 0.0006% daily turnover · Short 7% of daily vol

Income Trends

Revenue
$26M +130.4% ▲
Gross Profit
-$2M -249.0% ▼
Operating Income
-$122M -43.3% ▼
Net Income
-$57M +39.0% ▲
EPS (Diluted)
$-1.35 +91.8% ▲
EBITDA
-$48M +44.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022
Revenue$0$11M$26M
YoY Growth+0.0%+0.0%+130.4%
Cost of Revenue$0$10M$28M
Gross Profit$0$1M-$2M
Gross Margin—10.7%-7.0%
R&D Expenses$0$13M$19M
SG&A Expenses$0$71M$99M
Operating Expenses$0$86M$120M
Operating Income$0-$85M-$122M
Operating Margin—-759.7%-472.7%
Interest Expense$0$1M$991K
Income Before Tax-$15M-$93M-$55M
Tax Expense$0$17K$480K
Net Income-$15M-$94M-$57M
Net Margin—-837.9%-221.7%
EPS (Diluted)$-0.44$-16.41$-1.35
EBITDA-$15M-$88M-$48M
Shares Outstanding34M6M70M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms